Abstract:
Introduction. For the treatment of MDR and XDR tuberculosis, it is important to select the most
suitable drug regimen. The resistance testing procedure should be as fast and accurate as
possible. Within the framework of personalized medicine, the most suitable therapy approach for
the individual patient should be found. With the faster available information from a new form of
susceptibility testing, the best regimen could be created in a shorter period of time and the
appropriate therapy for the patient could be initiated.
